News

Technology News

Adimab Announces New Pharmaceutical Partnership

Monday, July 12, 2010 5:17:00 AM PDT | VentureDeal Staff
Lebanon, New Hampshire  --  Antibody discovery platform manufacturer Adimab has announced the fifth important pharmaceutical partnership agreement.

Collaborating with Novartis, the agreement initiates research to identify fully human antibodies against two targets selected by Novartis.

Adimab will receive upfront payments, milestone payments as well as licensing fees in the event the antibodies are commercialized.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1